medicalnewstoday.com
62%
539
Monoclonal antibodies for COVID-19: What do we know so far?
Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regulatory agencies around the world are evaluating monoclonal antibodies for use as a therapy to treat COVID-19.Monoclonal antibodies gained media attention with the news in October 2020 that Donald Trump had received the experimental Regeneron antibody treatment. They have since progressed to allow more widespread use.